TrialScientific reports2025

The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk.

F D Richard Hobbs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.